🇺🇸 InspireMD, Inc.NSPR
Get InspireMD, Inc. filings on Telegram the moment they are published.
Follow InspireMD, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 7.01, 8.01, 9.01
Overview: FDA approved the CGuard® Prime TransCarotid Stent System for use in TCAR procedures, supported by CGUARDIANS II trial data showing 100% acute device success.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest